(Q34743637)

4 August 2017

Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans (English)

1 reference

4 August 2017

1 reference

6

Harmatz JS

1 reference

4 August 2017

2

Greenblatt DJ

1 reference

4 August 2017

7

Shader RI

1 reference

4 August 2017

Kaplan GB

1

1 reference

4 August 2017

Ehrenberg BL

series ordinal

3

1 reference

4 August 2017

Goddard JE

series ordinal

4

1 reference

4 August 2017

Cotreau MM

series ordinal

5

1 reference

4 August 2017

language of work or name

1 reference

1 August 1997

1 reference

The Journal of Clinical Pharmacology

4 August 2017

1 reference

4 August 2017

37

1 reference

4 August 2017

693-703

1 reference

4 August 2017

8

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

4 August 2017

1 reference

Pharmacological rationale for the clinical use of caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Caffeine physical dependence: a review of human and laboratory animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Withdrawal syndrome after the double-blind cessation of caffeine consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Caffeine as a model drug of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Stimulus functions of caffeine in humans: relation to dependence potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Adenosine receptors: targets for future drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Adenosine receptors and behavioral actions of methylxanthines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Effects of caffeine on alertness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

The influence of caffeine on human EEG under resting conditions and during mental loads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Effects of caffeine and cyclizine alone and in combination on human performance, subjective effects and EEG activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Acute dose-effect relationships of caffeine and mental performance, EEG, cardiovascular and subjective parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Separate and combined effects of caffeine and alprazolam on motor activity and benzodiazepine receptor binding in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Increased anxiogenic effects of caffeine in panic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Anxiogenic effects of caffeine in patients with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Effects of single and repeated doses of theophylline on aspects of performance, electrophysiology and subjective assessments in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Sensitivity to triazolam in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Dose-dependency of caffeine metabolism with repeated dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

Sympathomimetic effects of paraxanthine and caffeine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1997.TB04356.X

10.1002/J.1552-4604.1997.TB04356.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference